Mclaren Port Huron

Mclaren Port Huron was paid $36.88M by Medicaid between Jan 2018 and Dec 2024, across 332 billing codes. Its largest line is 99284, emergency room visit (serious) — 17% of everything it billed.

33Billing provider infoMCLAREN PORT HURON
PORT HURON, MI 48060

33aNPI1982685384assigned 11/11/2005

33bProvider typeGeneral Acute Care Hospital

28Total paid$36.88M

24GClaims1,135,926

24DCodes billed332

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other General Acute Care Hospital providers in Michigan

Rank by total paid#35 of 86

Median peer was paid$21.55M

This provider vs. median1.7×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	154,575	$5.35M
2019	186,595	$5.59M
2020	151,838	$4.70M
2021	175,883	$5.85M
2022	169,446	$5.43M
2023	163,728	$5.25M
2024incomplete	133,861	$4.71M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	17%	34,422	31,387	$6.34M
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	15%	19,841	18,082	$5.63M
G0378	Hospital observation service, per hour	11%	11,446	6,549	$3.97M
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	11%	31,868	29,953	$3.91M
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	5.0%	21,626	19,153	$1.85M
G0463	Hospital outpatient clinic visit for assessment and management of a patient	4.0%	26,662	23,562	$1.49M
71046	Radiologic examination, chest; 2 views	2.1%	23,453	22,056	$792K
74177	Computed tomography, abdomen and pelvis; with contrast material	2.1%	5,777	5,597	$772K
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	1.8%	2,088	2,078	$680K
96361	Intravenous infusion, hydration; each additional hour	1.7%	21,896	16,895	$628K
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	1.4%	5,832	5,529	$511K
96375	Therapeutic injection; each additional sequential IV push	1.4%	18,094	14,390	$507K

320 more codes

87636	Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B	1.4%	6,699	$503K
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	1.3%	6,619	$476K
80061	Lipid panel	1.2%	13,376	$429K
99282	Emergency department visit for the evaluation and management, low to moderate severity	1.1%	5,687	$413K
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	<1%	19,789	$363K
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	<1%	2,378	$343K
70450	Computed tomography, head or brain; without contrast material	<1%	6,054	$291K
59025	Fetal non-stress test	<1%	3,416	$284K
45380	Colonoscopy, flexible; with biopsy, single or multiple	<1%	504	$250K
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	<1%	17,342	$247K
74176	Computed tomography, abdomen and pelvis; without contrast material	<1%	2,330	$240K
97112	Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination	<1%	11,491	$231K
77067	Screening mammography, bilateral, including computer-aided detection	<1%	4,438	$213K
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	1,534	$198K
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	<1%	938	$183K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	3,323	$177K
41899	Unlisted procedure, dentoalveolar structures	<1%	448	$177K
99291	Critical care, evaluation and management of the critically ill patient, first 30-74 minutes	<1%	483	$164K
76801		<1%	2,874	$164K
93975		<1%	1,471	$163K
72125	Computed tomography, cervical spine; without contrast material	<1%	2,461	$149K
71275	Computed tomographic angiography, chest, with contrast material	<1%	1,810	$148K
80053	Comprehensive metabolic panel	<1%	55,941	$139K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	5,721	$127K
84443	Thyroid stimulating hormone (TSH)	<1%	15,929	$126K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	<1%	2,318	$122K
76830	Ultrasound, transvaginal	<1%	2,129	$118K
47562		<1%	67	$116K
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	1,569	$116K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	7,446	$114K
94060		<1%	952	$111K
71045	Radiologic examination, chest; single view	<1%	3,513	$110K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	62,619	$109K
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	4,656	$109K
45378	Colonoscopy, flexible; diagnostic, including collection of specimen(s)	<1%	284	$106K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	1,067	$97K
97161		<1%	1,951	$93K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	1,829	$83K
97162		<1%	1,511	$77K
93971		<1%	1,490	$76K
76770		<1%	1,414	$74K
73721	Magnetic resonance imaging, any joint of lower extremity; without contrast material	<1%	607	$72K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	3,820	$61K
77066	Tomosynthesis, mammo	<1%	1,052	$57K
76536		<1%	1,124	$54K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	3,549	$54K
20611		<1%	351	$49K
72141		<1%	357	$49K
97597		<1%	734	$48K
95810	Polysomnography; sleep staging with 4 or more additional parameters	<1%	90	$46K
83036	Hemoglobin; glycosylated (A1C)	<1%	9,844	$46K
70551	Magnetic resonance imaging, brain; without contrast material	<1%	369	$43K
77065	Tomosynthesis, mammo	<1%	991	$41K
92507	Treatment of speech, language, voice, communication, and/or auditory processing disorder	<1%	977	$39K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	19,834	$39K
M0243	Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring	<1%	158	$39K
76642		<1%	971	$37K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	3,648	$35K
84439		<1%	7,570	$34K
72100		<1%	2,282	$30K
76641		<1%	576	$28K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	4,959	$27K
74018		<1%	5,255	$25K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	4,621	$25K
82607		<1%	3,371	$23K
82728		<1%	3,048	$21K
29515		<1%	293	$20K
87086	Culture, bacterial; quantitative colony count, urine	<1%	8,773	$20K
M0245	Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring	<1%	80	$19K
11042	Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm	<1%	119	$19K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	14,271	$19K
76805	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation	<1%	321	$17K
83970		<1%	801	$17K
83735		<1%	14,988	$17K
77063	Screening digital breast tomosynthesis, bilateral	<1%	1,330	$16K
84702		<1%	3,980	$16K
80048	Basic metabolic panel (calcium, ionized)	<1%	8,609	$16K
10060		<1%	187	$16K
78815	Positron emission tomography (PET) for limited area imaging	<1%	27	$15K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	1,447	$15K
73562		<1%	2,818	$15K
71271		<1%	260	$15K
85027		<1%	5,305	$15K
73610		<1%	2,440	$15K
83880		<1%	3,337	$14K
72050		<1%	551	$14K
82746		<1%	1,972	$14K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	839	$14K
93880		<1%	172	$14K
86003		<1%	284	$14K
73030		<1%	2,151	$14K
84484		<1%	14,293	$13K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	1,543	$13K
80074		<1%	654	$13K
73630		<1%	2,284	$13K
80306		<1%	7,040	$12K
83516		<1%	913	$12K
72110		<1%	464	$12K
83550		<1%	2,641	$11K
87186		<1%	3,773	$11K
97530	Therapeutic activities, direct patient contact, each 15 minutes	<1%	600	$11K
83540		<1%	3,148	$10K
87077		<1%	3,773	$10K
85730		<1%	14,414	$10K
93458		<1%	13	$10K
84481		<1%	1,174	$10K
87070		<1%	3,792	$10K
81025		<1%	13,846	$10K
71250		<1%	179	$9K
83605		<1%	8,269	$9K
83690		<1%	14,900	$9K
85610		<1%	15,971	$9K
73221		<1%	79	$9K
82947		<1%	510	$9K
G0279	Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066)	<1%	873	$9K
93017		<1%	271	$8K
81001		<1%	19,214	$8K
73130		<1%	1,962	$8K
86140		<1%	4,446	$8K
70486		<1%	370	$8K
87634		<1%	1,477	$8K
73110		<1%	1,230	$8K
87390		<1%	657	$8K
73502		<1%	886	$8K
36415	Collection of venous blood by venipuncture	<1%	59,834	$7K
86038		<1%	1,231	$7K
62323		<1%	26	$7K
86900		<1%	3,654	$7K
96367		<1%	399	$7K
77080		<1%	114	$7K
M0247	Intravenous infusion, sotrovimab, includes infusion and post administration monitoring	<1%	28	$6K
82565		<1%	3,177	$6K
82150		<1%	9,484	$6K
45385	Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s)	<1%	12	$6K
84425		<1%	537	$6K
M0222	Intravenous injection, bebtelovimab, includes injection and post administration monitoring	<1%	38	$6K
86850		<1%	2,621	$6K
70496		<1%	40	$5K
72131		<1%	129	$5K
72040		<1%	13	$5K
96376		<1%	9,557	$5K
86803		<1%	565	$4K
84100		<1%	3,211	$4K
84403		<1%	327	$4K
84520		<1%	2,395	$4K
82570		<1%	1,514	$4K
80076		<1%	995	$4K
85652		<1%	3,406	$4K
82550		<1%	4,717	$4K
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	<1%	12	$4K
85379		<1%	4,483	$4K
C9803	Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	276	$4K
84460		<1%	1,281	$3K
84450		<1%	1,271	$3K
84550		<1%	1,448	$3K
84153		<1%	339	$3K
87081		<1%	2,615	$3K
80051		<1%	994	$3K
81003		<1%	10,072	$3K
86780		<1%	369	$3K
87205		<1%	2,086	$3K
84134		<1%	322	$3K
G0103	Prostate cancer screening; prostate specific antigen test (psa)	<1%	248	$2K
87040		<1%	3,172	$2K
73140		<1%	238	$2K
86901		<1%	3,640	$2K
78226		<1%	12	$2K
99406		<1%	154	$2K
84255		<1%	151	$2K
88304		<1%	788	$2K
G0482	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed	<1%	54	$2K
73100		<1%	120	$2K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	82	$2K
82043		<1%	634	$2K
C8929	Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography	<1%	12	$2K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	28	$2K
82248		<1%	594	$2K
73560		<1%	86	$1K
86431		<1%	483	$1K
83615		<1%	670	$1K
84630		<1%	197	$1K
90686		<1%	73	$1K
87340		<1%	243	$1K
73080		<1%	277	$1K
83001		<1%	106	$1K
87522	Neg quan hep c or qual rna	<1%	42	$1K
82525		<1%	168	$1K
82785		<1%	144	$1K
97035		<1%	195	$1K
93351		<1%	13	$1K
84590		<1%	164	$983.52
95816		<1%	12	$937.62
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	8,864	$920.39
72170		<1%	665	$903.85
84112		<1%	15	$845.78
82075		<1%	4,010	$820.24
83655		<1%	124	$736.69
73590		<1%	257	$698.29
86665		<1%	45	$690.56
84703		<1%	448	$639.00
82247		<1%	204	$614.88
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	536	$565.22
87529		<1%	25	$562.25
70498		<1%	27	$550.59
83002		<1%	63	$538.99
74019		<1%	49	$518.23
70491		<1%	12	$511.40
73090		<1%	247	$504.22
82533		<1%	56	$500.64
71101		<1%	25	$477.05
88108		<1%	53	$475.67
87046		<1%	57	$471.64
82784		<1%	58	$376.67
80143		<1%	412	$349.22
80179		<1%	351	$333.78
86664		<1%	41	$290.94
72070		<1%	12	$286.50
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	11,218	$281.27
80164		<1%	70	$276.10
86225		<1%	50	$269.26
G0481	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed	<1%	14	$262.76
82140		<1%	37	$258.25
86663		<1%	42	$249.60
82105		<1%	27	$246.85
87045		<1%	57	$246.10
84402		<1%	13	$245.93
82272		<1%	288	$239.33
73120		<1%	12	$228.16
70360		<1%	42	$213.86
86376		<1%	27	$209.52
87430		<1%	1,920	$206.03
G0008	Administration of influenza virus vaccine	<1%	38	$192.42
87498		<1%	12	$189.32
84156		<1%	100	$187.77
87808		<1%	571	$157.97
87324		<1%	15	$133.65
87801	Infectious agent detection by nucleic acid; amplified probe, multiple organisms	<1%	259	$132.33
74022		<1%	27	$114.08
12001		<1%	381	$106.59
Q9950	Injection, sulfur hexafluoride lipid microspheres, per ml	<1%	41	$101.25
86762		<1%	12	$84.24
83721		<1%	15	$78.12
94726		<1%	334	$71.27
29125		<1%	245	$64.79
88342		<1%	53	$63.96
87075		<1%	27	$58.99
83520		<1%	666	$48.62
94760		<1%	706	$31.46
90715		<1%	1,225	$28.69
94729		<1%	322	$24.02
84145		<1%	39	$17.93
82009		<1%	210	$17.74
84132		<1%	14	$15.25
80178		<1%	12	$14.52
89050		<1%	16	$13.84
84157		<1%	12	$10.72
85045		<1%	15	$9.43
J2919	Injection, methylprednisolone sodium succinate, 5 mg	<1%	251	$7.50
86308		<1%	26	$6.82
J0665	Injection, bupivicaine, not otherwise specified, 0.5 mg	<1%	355	$5.77
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	4,117	$4.16
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	4,999	$4.03
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	3,218	$4.02
J1030	Injection, methylprednisolone acetate, 40 mg	<1%	1,237	$2.81
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	16,685	$1.66
J2001	Injection, lidocaine hcl for intravenous infusion, 10 mg	<1%	1,487	$0.79
J1644	Injection, heparin sodium, per 1000 units	<1%	5,144	$0.75
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	8,663	$0.58
J2704	Injection, propofol, 10 mg	<1%	9,678	$0.39
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	8,374	$0.19
J2270	Injection, morphine sulfate, up to 10 mg	0%	7,529	$0.00
J2405	Injection, ondansetron hydrochloride, per 1 mg	0%	17,761	$0.00
J1650	Injection, enoxaparin sodium, 10 mg	0%	464	$0.00
76942		0%	56	$0.00
Q9966	Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml	0%	377	$0.00
J2710	Injection, neostigmine methylsulfate, up to 0.5 mg	0%	1,923	$0.00
C1713	Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable)	0%	91	$0.00
C9113	Injection, pantoprazole sodium, per vial	0%	3,467	$0.00
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	0%	279	$0.00
J1756	Injection, iron sucrose, 1 mg	0%	302	$0.00
C1894	Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser	0%	460	$0.00
J0780	Injection, prochlorperazine, up to 10 mg	0%	107	$0.00
J7510	Prednisolone oral, per 5 mg	0%	100	$0.00
12011		0%	27	$0.00
J3475	Injection, magnesium sulfate, per 500 mg	0%	312	$0.00
J1596	Injection, glycopyrrolate, 0.1 mg	0%	100	$0.00
A9581	Injection, gadoxetate disodium, 1 ml	0%	369	$0.00
A9552	Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries	0%	27	$0.00
J2274	Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg	0%	26	$0.00
J1171	Injection, hydromorphone, 0.1 mg	0%	333	$0.00
A9537	Technetium tc-99m mebrofenin, diagnostic, per study dose, up to 15 millicuries	0%	14	$0.00
J1956	Injection, levofloxacin, 250 mg	0%	14	$0.00
J2765	Injection, metoclopramide hcl, up to 10 mg	0%	3,435	$0.00
G0283	Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care	0%	1,186	$0.00
J0690	Injection, cefazolin sodium, 500 mg	0%	3,978	$0.00
J0330	Injection, succinylcholine chloride, up to 20 mg	0%	2,949	$0.00
J2795	Injection, ropivacaine hydrochloride, 1 mg	0%	806	$0.00
J2360	Injection, orphenadrine citrate, up to 60 mg	0%	941	$0.00
J1100	Injection, dexamethasone sodium phosphate, 1 mg	0%	7,791	$0.00
J2371	Injection, phenylephrine hydrochloride, 20 micrograms	0%	142	$0.00
C1769	Guide wire	0%	724	$0.00
J3490	Unclassified drugs	0%	969	$0.00
J2060	Injection, lorazepam, 2 mg	0%	4,049	$0.00
J1170	Injection, hydromorphone, up to 4 mg	0%	10,433	$0.00
A9585	Injection, gadobutrol, 0.1 ml	0%	1,674	$0.00
J0131	Injection, acetaminophen, not otherwise specified,10 mg	0%	343	$0.00
J2370	Injection, phenylephrine hcl, up to 1 ml	0%	123	$0.00
J8540	Dexamethasone, oral, 0.25 mg	0%	72	$0.00
J1040	Injection, methylprednisolone acetate, 80 mg	0%	228	$0.00
J3411	Injection, thiamine hcl, 100 mg	0%	239	$0.00
J1790	Injection, droperidol, up to 5 mg	0%	15	$0.00
J0500	Injection, dicyclomine hcl, up to 20 mg	0%	42	$0.00
76870		0%	64	$0.00
J1010	Injection, methylprednisolone acetate, 1 mg	0%	160	$0.00
J3360	Injection, diazepam, up to 5 mg	0%	72	$0.00
82553		0%	2,337	$0.00
J2470	Injection, pantoprazole sodium, 40 mg	0%	271	$0.00
12002		0%	63	$0.00
J2175	Injection, meperidine hydrochloride, per 100 mg	0%	123	$0.00
Q9965	Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml	0%	45	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialCECAVA, ERIC (CEO)